Modelling approaches for estimating vaccine effectiveness of consecutive SARS-CoV-2 variant sublineages in the absence of study-specific genetic sequencing data, VEBIS hospital network, Europe, 2023/24.
Saved in:
| Title: | Modelling approaches for estimating vaccine effectiveness of consecutive SARS-CoV-2 variant sublineages in the absence of study-specific genetic sequencing data, VEBIS hospital network, Europe, 2023/24. |
|---|---|
| Authors: | Antunes L; Epiconcept, Paris, France., Nunes B; Epiconcept, Paris, France., Núñez O; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.; CIBER in Epidemiology and Public Health, Madrid, Spain., Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., Dockx Y; Scientific Directorate of Epidemiology and Public Health, Sciensano, Brussels, Belgium., Borg ML; Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta., Oroszi B; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Duffy R; Health Service Executive-Health Protection Surveillance Centre (HPSC), Dublin, Ireland., Dürwald R; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany., Kuliešė M; Department of Infectious Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania., Machado A; Epidemiology Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal., Petrović G; Croatian Institute of Public Health, Zagreb, Croatia., Lazăr M; 'Cantacuzino' National Medical-Military Institute for Research and Development, Bucharest, Romania., Guiomar R; Epidemiology Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal., Río VÁ; Dirección General de Salud Pública, Junta de Castilla y León, Valladolid, Spain., Castilla J; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., Magerman K; Department of Medical Microbiology - Infection Prevention and Control, Jessa Ziekenhuis, Hasselt, Belgium., Džiugytė A; Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta., Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Fitzgerald M; Health Service Executive-Health Protection Surveillance Centre (HPSC), Dublin, Ireland., Hackmann C; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany., Jančorienė L; Infectious Diseases and Dermatovenereology, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania., Gomez V; Epidemiology Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal., Makarić ZL; Croatian Institute of Public Health, Zagreb, Croatia., Popovici O; National Surveillance and Control Center for Communicable Diseases, National Institute of Public Health, Bucharest, Romania., Rojas-Castro M; Epiconcept, Paris, France., Rose AMC; Epiconcept, Paris, France. |
| Corporate Authors: | and the European Hospital Vaccine Effectiveness Group |
| Source: | PloS one [PLoS One] 2026 Mar 09; Vol. 21 (3), pp. e0343988. Date of Electronic Publication: 2026 Mar 09 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
